Nektar Therapeutics Reports First Quarter 2009 Financi... (ts and expenses 40009 61881...)

Nektar Therapeutics Reports First Quarter 2009 Financial Results

Date:5/6/2009

ts and expenses 40,009 61,881 Loss from operations (30,298) (41,889) Non-Operating income (expense): Interest income 1,650 5,013 Interest expense (3,337) (3,918) Other Income 45 302 --- --- Total non-operating income (expense) (1,642) 1,397 Loss before provision for income taxes (31,940) (40,492) Provision (benefit) for income taxes (133) 213 ---- --- Net income (loss) $(31,807) $(40,705) ======== ======== Basic and diluted net earnings (loss) per share $(0.34) $(0.44) Shares used in computing basic and diluted net earnings (loss) per share 92,516 92,330 NEKTAR THERAPEUTICS CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (unaudited) ASSETS March 31, December 31, 2009 2008 (1) --------- ------------ Current assets: Cash and cash equivalents $122,300 $155,584 Short-term investments 202,999 223,410 Accounts receivable, net of allowance 5,796 11,161 Inventory 13,392 9,319 Other current assets 6,108 6,746 ----- ----- Total current assets 350,595 406,220

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
2. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
3. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
4. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
5. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
6. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
7. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
8. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
9. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
10. West Concludes Agreement with Nektar
11. Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets

Post Your Comments:

(Date:12/15/2009)... 15 Repligen Corporation (Nasdaq: RGEN ... $731,000 in research funding to support the ongoing ... the Muscular Dystrophy Association (MDA). This grant ... testing and GMP manufacture of a drug candidate ... MDA not only provides important funding for Repligen,s ...

(Date:12/15/2009)... Reportlinker.com announces that a new ... catalogue: ,, The Future of ... 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The author ... of Orphan Diseases Therapeutics - Market Forecasts ...

(Date:12/15/2009)... Va., Dec. 15 AstraZeneca (NYSE: ... of Virginia (UVa) in Charlottesville, today announced ... research collaboration to enhance development of new ... with a secondary focus on peripheral vascular ... ) ,, The collaborative preclinical research projects ...

(Date:12/15/2009)... Company (NYSE: MOS ) plans to issue ... financial tables on Tuesday, January 5, 2010, after the ... Results will be available on Mosaic,s website at ... conference call with presentation slides on Wednesday, January 6, ... begin at 11:00 a.m. Eastern Standard Time (10:00 a.m. ...

[0] Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call

... Poole, an economic and community development specialist, presented a ... 2004 Governors Conference on Economic Development . Abstaining from ... keep and grow businesses in Wisconsin. , ,Wisconsin manufacturing ... breakdown, Poole said. He cited that Wisconsin saw only ...

... Wis. -- Bone Care International, Inc. announced Tuesday Herbert Conrad ... Mazess. Mazess will remain on the board of directors. ... the U.S. Pharmaceuticals Division of Hoffmann-La Roche, Inc. He served ... Inc. from 1996 to 2003, and was a co-founder of ...

... TeraMEDICA announced today Jim Prekop as president of ... from Peoplesoft where he recently served as ... to joining Peoplesoft, Prekop spent 14 years with Dun ... Hanna.said that the move will allow him to focus ...

Other Biology Technology:Optimistic Outlook For Manufacturing 2

Optimistic Outlook For Manufacturing Bone Care Names New Chairman TeraMEDICA Appoints Prekop as New President

(Date:12/15/2009)... treating devastating brain diseases such as Alzheimer,s and Parkinson,s, ... something to help a patient. , But they come ... majority of patients with ataxia disabling disorders that ... of Florida neurologists are trying to change that with ... the National Institute of Neurological Disorders and Stroke to ...

(Date:12/15/2009)... mammoths and ancient American horses may have been ... years longer than previously thought. After plucking ancient ... team of researchers used cutting-edge techniques to uncover ... samples dated to between 7,600 and 10,500 calendar ... one population of these now-extinct mammals endured longer ...

(Date:12/15/2009)... on society. It is estimated that 100 to 150 ... and it,s likely that rip currents account for more than ... rip current research and public understanding. Rip currents are ... most people do not know how to even identify, much ... the Rip Current Symposium is to identify advancements in rip ...

[0] UF to lead national effort to help patients with rare brain disease [0] Late-surviving megafauna exposed by ancient DNA in frozen soil [0] 1st International Rip Current Symposium

... pressure has finally seen the price of antiretroviral therapy for ... simple diagnostics to enable doctors to use these complex treatments ... New York universities believe they have the solution: a hand-held ... in seconds. At the moment it can take a week ...

... Many, if not all, plants maintain relationships with bacteria, ... to get rid of freeloaders, University of California, Berkeley, ... coastal California lupine that harbors nitrogen-fixing bacteria in its ... respond differently to bacteria that efficiently produce nitrogen than ...

... infection is small in Australia and people can still safely eat ... Bob Doneley. , "The chances of getting bird flu off ... UQ School of Veterinary Science Adjunct Professor Dr Doneley said. ... a meteor and fall on your head than somebody getting bird ...

Other Biology News:Cheap, rapid hand-held check for HIV 2 Plants, too, have ways to manage freeloaders 2 Plants, too, have ways to manage freeloaders 3 Plants, too, have ways to manage freeloaders 4 Expert dispels bird flu paranoia 2

Cheap, rapid hand-held check for HIV Plants, too, have ways to manage freeloaders Expert dispels bird flu paranoia

... comes with a shutter (controlled via a TTL ... The DH-2000 Deuterium Tungsten Halogen Light ... tungsten halogen light sources in a single optical ... stable output from 215-200 nm. In addition, deep-UV ...

... Analysis Note: Agglutination activity is expressed in g ... in phosphate buffered saline, pH 6.8, of a ... activity is the lowest concentration to agglutinate a ... after 1 hour incubation at 25 C. ...

... Security ChemStation is a ... application for data acquisition, ... searching and reporting, addressing ... data security, integrity, and ...

... These handy dispensers save ... glasses, wipers, hats, and other ... benchtop storage bins for small ... and manufacturing. Clear acrylic. Open-slot ...

Biology Products:

DH-2000 with integrated shutter from Ocean Optics Helix aspersa (garden snail) Lectin from Sigma-Aldrich Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies File Holder from Terra Universal, Inc.

Nektar Therapeutics Reports First Quarter 2009 Financi...(ts and expenses 40009 61881...)